KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Regeneron Pharmaceuticals (REGN) Return on Sales (2016 - 2025)

Historic Return on Sales for Regeneron Pharmaceuticals (REGN) over the last 17 years, with Q4 2025 value amounting to 0.22%.

  • Regeneron Pharmaceuticals' Return on Sales fell 200.0% to 0.22% in Q4 2025 from the same period last year, while for Dec 2025 it was 0.31%, marking a year-over-year change of 0.0%. This contributed to the annual value of 0.31% for FY2025, which is 0.0% changed from last year.
  • As of Q4 2025, Regeneron Pharmaceuticals' Return on Sales stood at 0.22%, which was down 200.0% from 0.39% recorded in Q3 2025.
  • In the past 5 years, Regeneron Pharmaceuticals' Return on Sales registered a high of 19.47% during Q1 2022, and its lowest value of 0.22% during Q4 2025.
  • Over the past 5 years, Regeneron Pharmaceuticals' median Return on Sales value was 0.37% (recorded in 2025), while the average stood at 1.89%.
  • As far as peak fluctuations go, Regeneron Pharmaceuticals' Return on Sales surged by 190300bps in 2022, and later tumbled by -192100bps in 2023.
  • Quarter analysis of 5 years shows Regeneron Pharmaceuticals' Return on Sales stood at 0.45% in 2021, then skyrocketed by 2559bps to 11.97% in 2022, then tumbled by -97bps to 0.34% in 2023, then fell by -28bps to 0.24% in 2024, then decreased by -10bps to 0.22% in 2025.
  • Its Return on Sales was 0.22% in Q4 2025, compared to 0.39% in Q3 2025 and 0.38% in Q2 2025.